HPP AMG :@0.171081:0.940294:0.280299:0.940294:0.280299:0.918072:0.171081:0.918072:0.016043:0.013639:0.013639:0.005905:0.014867:0.022549:0.016672:0.005905
Central Nervous Infections :@0.859501:0.940294:1.147591:0.940294:1.147591:0.918072:0.859501:0.918072:0.013665:0.013012:0.013717:0.008884:0.008910:0.012515:0.005905:0.005905:0.016670:0.013012:0.008962:0.011810:0.013770:0.014188:0.010086:0.005905:0.006584:0.013639:0.007708:0.013012:0.011314:0.008884:0.006010:0.013587:0.013717:0.010817:0.005905
 :@1.829525:0.940294:1.835430:0.940294:1.835430:0.918072:1.829525:0.918072:0.005905
29 :@1.802803:0.940294:1.835430:0.940294:1.835430:0.918072:1.802803:0.918072:0.013064:0.013658:0.005905
Infection/ Condition  :@0.261330:0.151462:0.497815:0.151462:0.497815:0.132723:0.261330:0.132723:0.006603:0.014181:0.007720:0.013064:0.013634:0.007720:0.006603:0.014751:0.014252:0.006603:0.006461:0.017197:0.014822:0.014252:0.014252:0.007102:0.007720:0.006603:0.014751:0.014252:0.007340:0.006603
Suggested Treatment :@0.870190:0.141395:1.119786:0.141395:1.119786:0.122655:0.870190:0.122655:0.016010:0.014252:0.014252:0.014252:0.013064:0.013634:0.007720:0.013064:0.014822:0.006603:0.014181:0.009477:0.013064:0.013064:0.007720:0.021354:0.013634:0.014252:0.008575:0.006603
Comments :@1.558076:0.151462:1.687601:0.151462:1.687601:0.132723:1.558076:0.132723:0.017197:0.014252:0.021354:0.021354:0.013064:0.013658:0.008290:0.013753:0.006603
Preferred :@0.733017:0.161597:0.838789:0.161597:0.838789:0.142857:0.733017:0.142857:0.016010:0.007720:0.013064:0.007102:0.013064:0.007720:0.007720:0.013064:0.013705:0.006603
Alternative :@1.145249:0.161597:1.264086:0.161597:1.264086:0.142857:1.145249:0.142857:0.016010:0.004751:0.006603:0.012993:0.008290:0.013064:0.013064:0.007102:0.005273:0.011354:0.013729:0.006603
 :@0.184739:0.181765:0.191342:0.181765:0.191342:0.163025:0.184739:0.163025:0.006603
Healthcare-associated :@0.184739:0.201092:0.443112:0.201092:0.443112:0.182353:0.184739:0.182353:0.017197:0.013064:0.013064:0.006603:0.008219:0.013658:0.013634:0.013064:0.009477:0.013219:0.007720:0.013064:0.013634:0.013064:0.014252:0.013064:0.007102:0.013064:0.007720:0.013634:0.014252:0.006603
ventriculitis and meningitis :@0.184739:0.220420:0.499002:0.220420:0.499002:0.201681:0.184739:0.201681:0.012470:0.013634:0.014252:0.007720:0.009477:0.006603:0.013563:0.014252:0.006603:0.006461:0.007720:0.007102:0.013064:0.006603:0.013563:0.014252:0.014252:0.006603:0.021283:0.013634:0.013658:0.007102:0.014252:0.014252:0.007102:0.007720:0.006603:0.013860:0.006603
 :@0.586295:0.181765:0.592898:0.181765:0.592898:0.163025:0.586295:0.163025:0.006603
Vancomycin  25-30mg/kg loading :@0.586295:0.201092:0.943800:0.201092:0.943800:0.182353:0.586295:0.182353:0.016010:0.013064:0.012470:0.011876:0.013064:0.020760:0.011283:0.012447:0.005273:0.012542:0.006603:0.006461:0.013634:0.013207:0.007720:0.013064:0.013064:0.020166:0.013064:0.006603:0.011805:0.013064:0.007102:0.005273:0.013135:0.013064:0.013634:0.005273:0.012542:0.013634:0.006603
dose then 15mg/kg IV q12h  :@0.586295:0.220420:0.889857:0.220420:0.889857:0.201681:0.586295:0.201681:0.013064:0.013064:0.011876:0.013064:0.006603:0.007031:0.012470:0.013634:0.013064:0.006603:0.012993:0.013064:0.020166:0.013064:0.006603:0.011805:0.013064:0.007102:0.005938:0.016010:0.007102:0.013064:0.013064:0.013634:0.012470:0.007340:0.006603
(not to exceed 2gm per dose) :@0.586295:0.239748:0.903515:0.239748:0.903515:0.221008:0.586295:0.221008:0.008314:0.012470:0.013064:0.006603:0.006461:0.006603:0.013563:0.006603:0.013563:0.011283:0.011876:0.013064:0.013064:0.013634:0.006603:0.012993:0.013064:0.020166:0.006603:0.012993:0.013064:0.007720:0.007102:0.013064:0.013634:0.011283:0.013848:0.008314:0.006603
 :@0.586295:0.259126:0.592898:0.259126:0.592898:0.240387:0.586295:0.240387:0.006603
PLUS :@0.586295:0.278454:0.656437:0.278454:0.656437:0.259714:0.586295:0.259714:0.016010:0.014252:0.017197:0.016081:0.006603
 :@0.586295:0.297782:0.592898:0.297782:0.592898:0.279042:0.586295:0.279042:0.006603
Ceftazidime 2 gm IV q8h :@0.586295:0.317109:0.853040:0.317109:0.853040:0.298370:0.586295:0.298370:0.017197:0.013064:0.007102:0.006603:0.012993:0.011876:0.004751:0.013634:0.004751:0.020166:0.013064:0.006603:0.012993:0.006603:0.012993:0.020333:0.006532:0.005938:0.016033:0.006532:0.013658:0.013658:0.013064:0.006603
OR :@0.586295:0.336437:0.628527:0.336437:0.628527:0.317697:0.586295:0.317697:0.018409:0.017221:0.006603
Meropenem 2 gm IV q8h :@0.586295:0.355765:0.854228:0.355765:0.854228:0.337025:0.586295:0.337025:0.019596:0.013064:0.007720:0.013064:0.013634:0.013634:0.012470:0.013064:0.020166:0.006603:0.012993:0.006603:0.012993:0.020309:0.007126:0.005938:0.016033:0.006532:0.013064:0.013634:0.013088:0.006603
 :@0.586295:0.375126:0.592898:0.375126:0.592898:0.356387:0.586295:0.356387:0.006603
 :@1.005059:0.181765:1.011663:0.181765:1.011663:0.163025:1.005059:0.163025:0.006603
 :@1.423800:0.181765:1.430404:0.181765:1.430404:0.163025:1.423800:0.163025:0.006603
Vancomycin trough level should be :@1.423800:0.201092:1.797743:0.201092:1.797743:0.182353:1.423800:0.182353:0.016010:0.013064:0.012470:0.011876:0.013064:0.020760:0.011283:0.012447:0.005273:0.012542:0.006603:0.006461:0.008290:0.013634:0.012470:0.013634:0.013064:0.006603:0.005273:0.013634:0.011283:0.013634:0.004751:0.007102:0.011876:0.012470:0.013634:0.013064:0.005273:0.013135:0.006603:0.012993:0.013064:0.006603
10-14 mmol/L or 15-20 mcg/L :@1.423800:0.220420:1.742280:0.220420:1.742280:0.201681:1.423800:0.201681:0.013064:0.013064:0.007720:0.013064:0.013064:0.006603:0.020095:0.020166:0.013064:0.004751:0.007102:0.013064:0.006603:0.012993:0.007720:0.007102:0.013064:0.013230:0.007720:0.013634:0.013064:0.006603:0.020095:0.011876:0.013064:0.006603:0.013682:0.006603
 :@1.423800:0.239748:1.430404:0.239748:1.430404:0.221008:1.423800:0.221008:0.006603
Empirical treatment should be :@1.423800:0.259126:1.743777:0.259126:1.743777:0.240387:1.423800:0.240387:0.016010:0.020166:0.013064:0.004751:0.007720:0.004751:0.012447:0.013064:0.005273:0.006603:0.006532:0.007720:0.013634:0.013064:0.006603:0.020095:0.013064:0.013064:0.006603:0.007031:0.011876:0.012470:0.013634:0.013064:0.005273:0.013135:0.006603:0.012993:0.013064:0.006603
decided by the primary team based :@1.423800:0.278454:1.800974:0.278454:1.800974:0.259714:1.423800:0.259714:0.013064:0.013064:0.011876:0.005321:0.013064:0.013064:0.013064:0.006603:0.013563:0.011876:0.006532:0.007102:0.012470:0.013064:0.007268:0.013064:0.008290:0.004751:0.020166:0.013064:0.008290:0.011354:0.006532:0.006603:0.012993:0.013064:0.020166:0.006603:0.012993:0.013634:0.011876:0.013064:0.013064:0.006603
on local antibiogram.  :@1.423800:0.297782:1.656128:0.297782:1.656128:0.279042:1.423800:0.279042:0.013064:0.013064:0.006603:0.005273:0.013064:0.011876:0.013634:0.004751:0.006603:0.013563:0.013064:0.006603:0.005273:0.013634:0.004751:0.013064:0.013064:0.008290:0.013064:0.020166:0.006603:0.006651:0.006603
 :@1.423800:0.317109:1.430404:0.317109:1.430404:0.298370:1.423800:0.298370:0.006603
 :@0.184739:0.395294:0.191342:0.395294:0.191342:0.376555:0.184739:0.376555:0.006603
Cranial trauma :@0.184739:0.414622:0.357672:0.414622:0.357672:0.395882:0.184739:0.395882:0.017197:0.009477:0.013064:0.013658:0.006603:0.013563:0.006603:0.006520:0.007720:0.009477:0.013634:0.013658:0.021354:0.013800:0.006603
Open fracture :@0.184739:0.433950:0.346211:0.433950:0.346211:0.415210:0.184739:0.415210:0.018409:0.014252:0.013634:0.013658:0.007102:0.007720:0.009477:0.013064:0.013064:0.008290:0.013658:0.009477:0.013064:0.006603
 :@0.346912:0.433950:0.353515:0.433950:0.353515:0.415210:0.346912:0.415210:0.006603
Penetrating injuries :@0.184739:0.453277:0.412898:0.453277:0.412898:0.434538:0.184739:0.434538:0.016033:0.013064:0.014252:0.013064:0.007720:0.009477:0.013064:0.007720:0.007102:0.014252:0.014252:0.006603:0.007031:0.014252:0.007102:0.013658:0.009477:0.006603:0.012993:0.013836:0.006603
 :@0.586295:0.395294:0.592898:0.395294:0.592898:0.376555:0.586295:0.376555:0.006603
Amoxicillin/clavulanic acid 1.2gm IV :@0.586295:0.414622:0.967696:0.414622:0.967696:0.395882:0.586295:0.395882:0.016010:0.020166:0.013064:0.011283:0.004751:0.012447:0.005273:0.005392:0.005273:0.005392:0.012565:0.006556:0.012447:0.004751:0.013634:0.011876:0.013064:0.005273:0.013705:0.013064:0.004751:0.011995:0.006532:0.013064:0.012447:0.004751:0.013064:0.007102:0.013064:0.006603:0.012993:0.013064:0.020166:0.007268:0.005938:0.016010:0.006603
q8H :@0.586295:0.433950:0.636247:0.433950:0.636247:0.415210:0.586295:0.415210:0.013064:0.013064:0.017221:0.006603
 :@1.005059:0.395294:1.011663:0.395294:1.011663:0.376555:1.005059:0.376555:0.006603
Cefuroxime 1.5 gm IV q8H :@1.005059:0.414622:1.291401:0.414622:1.291401:0.395882:1.005059:0.395882:0.017197:0.013064:0.007102:0.012470:0.007720:0.013634:0.011283:0.004751:0.020760:0.013064:0.006603:0.012993:0.006603:0.012993:0.007102:0.013064:0.020166:0.006603:0.005867:0.016010:0.006603:0.012993:0.013064:0.018029:0.006603
 :@1.005059:0.433950:1.011663:0.433950:1.011663:0.415210:1.005059:0.415210:0.006603
PLUS :@1.005059:0.453277:1.075202:0.453277:1.075202:0.434538:1.005059:0.434538:0.016010:0.014252:0.017197:0.016081:0.006603
Metronidazole 500 mg IV q8H :@1.005059:0.472639:1.325891:0.472639:1.325891:0.453899:1.005059:0.453899:0.019596:0.013064:0.006603:0.007648:0.013634:0.013064:0.005273:0.013135:0.013064:0.011876:0.013634:0.004751:0.013064:0.007102:0.013064:0.013064:0.013064:0.006603:0.020095:0.013064:0.007102:0.005938:0.016010:0.006603:0.012993:0.013064:0.018052:0.006603
 :@1.005059:0.491966:1.011663:0.491966:1.011663:0.473227:1.005059:0.473227:0.006603
 :@1.423800:0.395294:1.430404:0.395294:1.430404:0.376555:1.423800:0.376555:0.006603
Duration 5-7 days :@1.423800:0.414622:1.618124:0.414622:1.618124:0.395882:1.423800:0.395882:0.017197:0.012470:0.008290:0.013064:0.007102:0.004751:0.013634:0.012470:0.007102:0.013254:0.007720:0.013064:0.006603:0.013563:0.013634:0.011876:0.011924:0.006603
 :@0.184739:0.512134:0.191342:0.512134:0.191342:0.493395:0.184739:0.493395:0.006603
Neurosyphilis :@0.184739:0.531462:0.348765:0.531462:0.348765:0.512723:0.184739:0.512723:0.017197:0.013634:0.013658:0.009477:0.014252:0.013064:0.013064:0.014822:0.014252:0.006603:0.006461:0.007102:0.013836:0.006603
 :@0.586295:0.512134:0.592898:0.512134:0.592898:0.493395:0.586295:0.493395:0.006603
Refer to section (Sexually Transmitted Infections) :@0.586295:0.531462:1.112019:0.531462:1.112019:0.512723:0.586295:0.512723:0.017197:0.013064:0.007102:0.013064:0.007720:0.006603:0.006461:0.013064:0.006603:0.011805:0.013064:0.011876:0.007102:0.004751:0.013634:0.012470:0.007102:0.007720:0.016010:0.013634:0.011283:0.013064:0.013634:0.005273:0.005392:0.011283:0.006603:0.014751:0.007720:0.013634:0.013064:0.011283:0.020166:0.004751:0.007102:0.006603:0.012993:0.013064:0.007102:0.006603:0.012399:0.007102:0.013064:0.011876:0.007102:0.004751:0.013634:0.013064:0.011876:0.008836:0.006603
 :@0.586295:0.550790:0.592898:0.550790:0.592898:0.532050:0.586295:0.532050:0.006603
 :@0.171081:0.570975:0.177684:0.570975:0.177684:0.552269:0.171081:0.552269:0.006603
Reference: :@0.171081:0.590303:0.294062:0.590303:0.294062:0.571597:0.171081:0.571597:0.017197:0.013064:0.006603:0.012993:0.007720:0.013064:0.013064:0.012447:0.013064:0.007162:0.006603
1.  Brouwer MC et al. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD004405 :@0.213836:0.609630:1.767221:0.609630:1.767221:0.590924:0.213836:0.590924:0.013064:0.006532:0.006603:0.016544:0.016010:0.007720:0.013064:0.013064:0.017197:0.013064:0.007720:0.006603:0.019525:0.017197:0.007102:0.013064:0.006603:0.006461:0.013064:0.005273:0.006603:0.006532:0.017197:0.013634:0.007720:0.006603:0.005273:0.011876:0.013064:0.011876:0.006532:0.013634:0.007720:0.013064:0.005273:0.013135:0.011876:0.006532:0.006603:0.013563:0.007720:0.006603:0.012993:0.011876:0.013064:0.007102:0.013064:0.006603:0.012993:0.013064:0.011876:0.007102:0.013064:0.007720:0.005273:0.013135:0.005273:0.007031:0.020166:0.013064:0.013634:0.005273:0.013135:0.013064:0.005273:0.006603:0.005321:0.011876:0.006532:0.006603:0.017150:0.013064:0.011876:0.013064:0.007720:0.013634:0.013064:0.013064:0.006603:0.017150:0.013064:0.007102:0.013064:0.013064:0.013064:0.011876:0.013064:0.007102:0.013064:0.006603:0.006461:0.016010:0.011876:0.011876:0.006532:0.013064:0.019596:0.013634:0.006603:0.005273:0.011876:0.006532:0.017197:0.013064:0.011876:0.005321:0.013634:0.016627:0.011876:0.006532:0.013064:0.013634:0.013064:0.013064:0.006603:0.007031:0.005938:0.011876:0.011876:0.013634:0.013064:0.006603:0.012993:0.006603:0.006461:0.016010:0.007720:0.006603:0.007031:0.006603:0.017150:0.013064:0.006603:0.006461:0.006603:0.017150:0.017197:0.013064:0.013634:0.013064:0.013064:0.013064:0.014371:0.006603
2.  Pasquale Pagliano et al. Listeria monocytogenes meningitis in the elderly: epidemiological, clinical and therapeutic findings. Le Infezioni in Medicina, :@0.213836:0.628958:1.835819:0.628958:1.835819:0.610252:0.213836:0.610252:0.013064:0.006532:0.006603:0.016544:0.016010:0.013064:0.011876:0.013064:0.013064:0.013064:0.005273:0.013135:0.007102:0.016010:0.013634:0.013064:0.005273:0.005392:0.013064:0.013064:0.013634:0.007102:0.013064:0.007102:0.007102:0.013064:0.005273:0.006603:0.007696:0.013064:0.005273:0.011924:0.006603:0.012993:0.007720:0.005273:0.013705:0.007102:0.020166:0.013064:0.013064:0.013064:0.011876:0.011876:0.006532:0.013634:0.013064:0.013064:0.013064:0.013064:0.012447:0.007102:0.019596:0.013634:0.013064:0.005273:0.013135:0.013634:0.005273:0.006603:0.005321:0.011876:0.007102:0.005273:0.013135:0.007102:0.007102:0.013064:0.013064:0.007696:0.013064:0.005273:0.013135:0.013064:0.007720:0.005273:0.011924:0.007102:0.007102:0.013064:0.013064:0.005914:0.013064:0.013064:0.019596:0.005273:0.013135:0.005273:0.013705:0.013064:0.005273:0.011924:0.013064:0.005273:0.006603:0.007102:0.011876:0.005321:0.005273:0.013135:0.005273:0.011924:0.013064:0.005914:0.007102:0.013064:0.013634:0.013064:0.007102:0.007102:0.013064:0.013064:0.007720:0.013634:0.013064:0.013064:0.013064:0.006603:0.005843:0.011876:0.007102:0.006603:0.005273:0.013064:0.013064:0.005273:0.013135:0.013064:0.013872:0.006532:0.007126:0.013634:0.013064:0.007696:0.006603:0.012993:0.006603:0.013563:0.011283:0.005273:0.013135:0.013064:0.005914:0.007102:0.005273:0.013705:0.007102:0.019596:0.013064:0.013064:0.005273:0.011924:0.005273:0.013705:0.013064:0.007102:0.006603
n. 2, 105-111, 2016 :@0.256580:0.648286:0.469311:0.648286:0.469311:0.629580:0.256580:0.629580:0.013064:0.006603:0.006461:0.013064:0.006603:0.006461:0.013064:0.013634:0.013159:0.007720:0.013064:0.013634:0.013064:0.006603:0.006461:0.013064:0.013682:0.013064:0.013658:0.006603
3.  van de Beek, D. et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clinical Microbiology and  Infection, Volume 22 , S37 :@0.213836:0.667647:1.835843:0.667647:1.835843:0.648941:0.213836:0.648941:0.013064:0.006532:0.006603:0.016544:0.011876:0.013064:0.013064:0.007102:0.013064:0.013064:0.007102:0.016010:0.013064:0.013064:0.011876:0.006532:0.007102:0.017197:0.006603:0.007031:0.013064:0.006603:0.007031:0.013064:0.005273:0.006603:0.007102:0.016010:0.016010:0.017197:0.019596:0.005938:0.017197:0.007102:0.013064:0.013064:0.005914:0.013064:0.013064:0.005273:0.005392:0.013064:0.013064:0.006603:0.007031:0.013064:0.005273:0.013705:0.013064:0.013064:0.013064:0.011876:0.005321:0.011876:0.007102:0.013064:0.013634:0.013064:0.007102:0.006603:0.007648:0.013064:0.013064:0.006603:0.019525:0.013634:0.013064:0.006603:0.007031:0.013064:0.006603:0.007031:0.013064:0.011876:0.013064:0.007102:0.013064:0.007102:0.013064:0.013064:0.011876:0.006532:0.013634:0.007720:0.005273:0.013135:0.005273:0.007173:0.019596:0.013064:0.013064:0.005273:0.013705:0.013064:0.005273:0.006603:0.005321:0.011876:0.006532:0.007102:0.017197:0.005273:0.005392:0.013064:0.005273:0.011924:0.013064:0.005273:0.007173:0.019596:0.005273:0.011924:0.007720:0.013064:0.013064:0.005273:0.013135:0.005273:0.013705:0.013064:0.011876:0.007102:0.013064:0.013064:0.013064:0.007102:0.007102:0.006603:0.014371:0.006603:0.012993:0.011876:0.006532:0.005273:0.013705:0.013064:0.006603:0.007031:0.016010:0.013064:0.005273:0.013135:0.019596:0.013064:0.007102:0.013064:0.013064:0.007102:0.006603:0.007031:0.016010:0.013634:0.013634:0.006603
- S62  :@0.256580:0.686975:0.326793:0.686975:0.326793:0.668269:0.256580:0.668269:0.007720:0.006532:0.016010:0.013064:0.013064:0.007221:0.006603
4.  McGill,  F.  et  al.  The  UK  joint  specialist  societies  guideline  on  the  diagnosis  and  management  of  acute  meningitis  and  meningococcal  sepsis  in :@0.213836:0.706319:1.835677:0.706319:1.835677:0.687613:0.213836:0.687613:0.013064:0.006532:0.006603:0.016544:0.019596:0.011876:0.018409:0.005273:0.005392:0.005273:0.006603:0.006603:0.004062:0.014252:0.006603:0.006603:0.003990:0.013064:0.006603:0.006603:0.003990:0.013064:0.005273:0.006603:0.006603:0.004846:0.014252:0.013064:0.013064:0.006603:0.004062:0.017197:0.016010:0.006603:0.004062:0.005273:0.013135:0.005273:0.013135:0.006603:0.006603:0.003990:0.011876:0.013634:0.013064:0.011876:0.005321:0.013064:0.005273:0.005392:0.011876:0.006532:0.006603:0.004062:0.011876:0.013064:0.011876:0.005321:0.013064:0.006603:0.005273:0.013064:0.011876:0.006603:0.004656:0.013064:0.013064:0.005273:0.013135:0.013064:0.005914:0.005273:0.013135:0.013064:0.006603:0.004062:0.013064:0.013064:0.006603:0.004062:0.006603:0.012993:0.013064:0.006603:0.004656:0.013064:0.005273:0.013135:0.013064:0.013634:0.013064:0.011876:0.005321:0.011876:0.006603:0.004062:0.013064:0.013064:0.013064:0.006603:0.004062:0.020166:0.013064:0.013064:0.013064:0.013634:0.013064:0.019596:0.013634:0.013064:0.006603:0.006603:0.003990:0.013064:0.007363:0.006603:0.004086:0.013064:0.011876:0.013634:0.006603:0.012993:0.006603:0.004062:0.019596:0.013634:0.013064:0.005273:0.013705:0.013064:0.005273:0.006603:0.005321:0.011876:0.006603:0.004062:0.013064:0.013064:0.013064:0.006603:0.004062:0.019596:0.013634:0.013064:0.005273:0.013135:0.013064:0.013064:0.012447:0.013064:0.011876:0.011876:0.013064:0.005273:0.006603:0.004133:0.011876:0.013064:0.013064:0.011876:0.005321:0.011876:0.006603:0.004062:0.005273:0.013705:0.006603
immunocompetent adults. Journal of Infection, Volume 7 , Issue 4 , 405 – 438. :@0.256580:0.725630:1.084703:0.725630:1.084703:0.706924:0.256580:0.706924:0.005273:0.019667:0.019596:0.013064:0.013064:0.013064:0.012447:0.013064:0.019596:0.013064:0.013064:0.007102:0.013064:0.013064:0.006603:0.006461:0.013634:0.013064:0.013064:0.005273:0.006603:0.011876:0.006746:0.006532:0.011876:0.013634:0.013064:0.007720:0.013064:0.013064:0.005273:0.007173:0.013064:0.006603:0.007031:0.005938:0.013064:0.007102:0.013064:0.011876:0.006532:0.005273:0.013135:0.013064:0.006603:0.006461:0.016010:0.013064:0.005273:0.013705:0.019596:0.013064:0.006603:0.012993:0.007102:0.007102:0.006603:0.005867:0.011876:0.011876:0.013634:0.013064:0.006603:0.012993:0.006603:0.006461:0.007102:0.013064:0.013064:0.013064:0.007482:0.013064:0.006532:0.013064:0.013064:0.013064:0.007126:0.006603
5.  Allan R. Tunkel et al. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis, :@0.213836:0.744958:1.835914:0.744958:1.835914:0.726252:0.213836:0.726252:0.013064:0.006532:0.006603:0.016544:0.016010:0.005273:0.005392:0.013064:0.013064:0.005938:0.017197:0.006603:0.005867:0.014252:0.013064:0.013064:0.012447:0.013064:0.005273:0.006010:0.013064:0.006603:0.006461:0.013064:0.005273:0.006603:0.006105:0.013064:0.013634:0.013064:0.013064:0.006603:0.005867:0.013634:0.006603:0.012993:0.011876:0.006532:0.005273:0.013135:0.013064:0.012447:0.005938:0.017197:0.005273:0.011924:0.013064:0.013064:0.011876:0.013064:0.011876:0.005938:0.016010:0.013064:0.011876:0.005321:0.013634:0.006603:0.011805:0.005938:0.013064:0.006603:0.006461:0.016010:0.019596:0.013064:0.007720:0.005273:0.011924:0.013634:0.004751:0.011876:0.005938:0.017197:0.005273:0.005392:0.013064:0.005273:0.011924:0.013064:0.005273:0.006010:0.016010:0.007720:0.013064:0.011876:0.006532:0.005273:0.012518:0.013064:0.005938:0.018409:0.013064:0.005273:0.013705:0.013064:0.005273:0.005392:0.013064:0.013064:0.011876:0.005938:0.006603:0.013563:0.007720:0.005938:0.017197:0.013064:0.013064:0.005273:0.007173:0.013064:0.011876:0.013064:0.007720:0.014466:0.007696:0.016010:0.011876:0.011876:0.013064:0.011876:0.005321:0.013064:0.006603:0.012993:0.013064:0.005938:0.016010:0.013064:0.013634:0.006603:0.007648:0.005273:0.011924:0.013254:0.005273:0.005392:0.006603:0.005273:0.011876:0.005938:0.013634:0.013064:0.013064:0.005938:0.020166:0.013064:0.013064:0.005273:0.013135:0.013064:0.005273:0.006603:0.005321:0.012447:0.007102:0.006603
Clinical Infectious Diseases, Volume 64, Issue 6, 15 March 2017,  :@0.256580:0.767277:0.954062:0.767277:0.954062:0.748571:0.256580:0.748571:0.017197:0.005273:0.005392:0.013064:0.005273:0.011924:0.013064:0.005273:0.006603:0.005938:0.013634:0.006603:0.012993:0.011876:0.006532:0.005273:0.013135:0.013064:0.011876:0.006532:0.017197:0.005273:0.011924:0.013634:0.013064:0.011876:0.013064:0.012185:0.006603:0.006461:0.016010:0.013064:0.005273:0.013135:0.020166:0.013064:0.006603:0.012993:0.013064:0.007102:0.007102:0.005938:0.011876:0.011876:0.013064:0.013064:0.007102:0.013064:0.006603:0.006461:0.013064:0.013064:0.007102:0.019596:0.013064:0.007720:0.012447:0.013064:0.006603:0.012993:0.013064:0.013064:0.013064:0.007102:0.007435:0.006603
6.  Peter R. Williamson et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nature Reviews Neurology volume 13, pages :@0.213836:0.789546:1.836033:0.789546:1.836033:0.770840:0.213836:0.770840:0.013064:0.006532:0.006603:0.016544:0.016010:0.013064:0.006603:0.012993:0.007720:0.007696:0.017197:0.006603:0.007625:0.022542:0.005273:0.005392:0.005273:0.005392:0.013064:0.019596:0.011876:0.013064:0.013064:0.007696:0.013064:0.006603:0.007625:0.013064:0.005273:0.006603:0.007696:0.017791:0.007720:0.011876:0.013064:0.006603:0.012993:0.011876:0.013064:0.011876:0.012447:0.013064:0.005273:0.007767:0.019596:0.013064:0.013064:0.005273:0.013705:0.013064:0.005273:0.006603:0.005321:0.011876:0.006532:0.007696:0.013064:0.013064:0.005273:0.013135:0.013634:0.019596:0.005273:0.013135:0.005273:0.013135:0.013064:0.011876:0.006532:0.007696:0.005273:0.019667:0.020166:0.013064:0.013064:0.013064:0.005273:0.013705:0.013064:0.011876:0.006532:0.007696:0.013064:0.005273:0.013135:0.013064:0.013634:0.013064:0.011876:0.005321:0.011876:0.007696:0.013064:0.013064:0.013064:0.007696:0.007102:0.013064:0.013064:0.007720:0.013634:0.013064:0.012874:0.006603:0.007625:0.017197:0.013064:0.006603:0.013563:0.007720:0.013064:0.007696:0.017197:0.013634:0.011876:0.005321:0.013064:0.016627:0.011876:0.007696:0.017197:0.013064:0.013634:0.007720:0.013064:0.005273:0.013135:0.013064:0.012185:0.007720:0.011876:0.013064:0.005914:0.013064:0.019596:0.013064:0.007696:0.013634:0.013183:0.006603:0.007625:0.013064:0.013064:0.013634:0.013064:0.012447:0.006603
13–24 (2017) :@0.256580:0.811815:0.404584:0.811815:0.404584:0.793109:0.256580:0.793109:0.013064:0.013064:0.013064:0.013064:0.013064:0.007102:0.007720:0.013064:0.013064:0.013634:0.013064:0.008432:0.006603
7.  The Sanford Guide to Antimicrobial Therapy 2018:@0.213836:0.833664:0.778884:0.833664:0.778884:0.814958:0.213836:0.814958:0.013064:0.006532:0.006603:0.016544:0.014252:0.013064:0.013064:0.006603:0.015938:0.013064:0.013064:0.007102:0.013064:0.007720:0.013064:0.006603:0.018907:0.013064:0.005273:0.013135:0.013064:0.006603:0.006461:0.013634:0.006603:0.015938:0.013064:0.006603:0.005273:0.019596:0.005273:0.011924:0.007720:0.013634:0.013064:0.005273:0.013135:0.005273:0.006603:0.014252:0.013634:0.013064:0.007720:0.013064:0.013064:0.012447:0.006603:0.012993:0.013468:0.013064:0.013207